Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

A 9671: Relates to including a representative of the drug or medical device manufacturer industry on the state board of pharmacy

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 9671 is a bill introduced in the New York House on January 21, 2026. According to its official title, it concerns: Relates to including a representative of the drug or medical device manufacturer industry on the state board of pharmacy. Primary sponsor: Michael Cashman (Democratic). Most recent recorded action (January 21, 2026): REFERRED TO HIGHER EDUCATION.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Provides that there shall be a representative of the drug or medical device manufacturer industry on the state board of pharmacy.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Michael CashmanPrimary sponsorDemocraticHouse115

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO HIGHER EDUCATION

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source